AVDL Avadel Pharmaceuticals plc

2.07
+0.09  (+5%)
Previous Close 1.98
Open 1.88
Price To Book -4.4
Market Cap 77,522,121
Shares 37,450,300
Volume 140,076
Short Ratio
Av. Daily Volume 306,036

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved June 3, 2013.
Bloxiverz (neostigmine methylsulfate)
Reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery
Announced approval May 2 2016
Akovaz
Hypotension
Phase 3 enrolment to be completed 2H 2020.
FT 218
Excessive daytime sleepiness and cataplexy in patients suffering from narcolepsy
Approved June 30 2014.
VAZCULEP (phenylephrine hydrochloride)
Clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia
Approved Jun 3 2013
Bloxiverz (neostigmine methylsulfate)
Reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery
PDUFA date extended by three months to December 15, 2019.
AV001
Hospital product

Latest News

  1. Jazz (JAZZ) Acquires Cavion, Adds Movement Disorder Candidate
  2. Avadel Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Company Update
  3. Avadel Pharmaceuticals Receives New PDUFA Date for AV001 of December 15, 2019
  4. Avadel Pharmaceuticals Further Strengthens Clinical and Medical Team
  5. Avadel Pharmaceuticals to Report Second Quarter 2019 Financial Results
  6. Do Directors Own Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares?
  7. Jazz (JAZZ) Acquires Early-Stage Precision Oncology Asset
  8. Jazz's (JAZZ) New Sleep Drug Sunosi Gets Schedule IV Status
  9. Avadel to Present New Data on Once-Nightly Sodium Oxybate at SLEEP 2019 Conference
  10. Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Executive Officer
  11. Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for AV001
  12. Introducing Avadel Pharmaceuticals (NASDAQ:AVDL), The Stock That Tanked 82%
  13. Avadel: 1Q Earnings Snapshot
  14. Avadel Pharmaceuticals Reports First Quarter 2019 Financial Results
  15. Avadel Pharmaceuticals Plc to Host Earnings Call
  16. Avadel Pharmaceuticals to Report First Quarter 2019 Financial Results
  17. Avadel Pharmaceuticals Announces Appointment of Jordan Dubow, M.D., as Chief Medical Officer
  18. Jazz's Xyrem Follow-On Drug Succeeds in Phase III Study
  19. Jazz Pharmaceuticals' Sleep Drug NDA Awaits FDA Decision